Interpharm - Worst Pharma Stocks of 2007

Company: Interpharm
Starting stock price: $2.06
Ending stock price: $0.43
Percent Change: -79.13%

Details: Interpharm makes generic versions of about a dozen prescription and over-the-counter meds, including acetaminophen and hydrocodone. It sells its products under its own name and under private labels. It’s trying to expand its product line into hormone products and and specialized delivery versions such as soft gels and liquids. In October it announced it would be late with its 10-K filing and as a result saw its stock stop trading because of AMEX rules.

Interpharm - Worst Pharma Stocks of 2007
Read more on

Suggested Articles

Oklahoma politicians contend J&J should be on the line for future abatement costs even after a $572 million verdict, but J&J sees things differently.

Abbott helmsman Miles White, who oversaw the spinoffs of AbbVie and Hospira, will step down as CEO after 21 years at the top job.

Mylan is the most recent drugmaker facing the FDA's ire over a tainted API that led to a global recall of "sartan"-based drugs last year.